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ABSTRACT The intrinsic capacity of the immune system
to elicit immune response selectively against late developing
sperm proteins has been mobilized to intercept spermatogenesis.
Bacillus Calmette-Guerin given in appropriate doses intrates-
ticularly is effective in bringing about this effect. In dogs and
rhesus monkeys, the sperm count in the semen declined pre-
cipitously, and almost complete azospermia was attained in 4-6
weeks after immunization. The few sperm cells that were
present were immotile. Examination of serial sections of testes
in immunized rats showed about 98% of the tubules to be de-
void of sperm. The tubules were partially or fully atrophied. The
basement membrane was, however, intact and the peritubular
cell layer was normal. Sertoli cell nuclei were apparently normal
but the cytoplasm was vacuolated and, in most cells, partially
disintegrated. The lumen of the tubules was exhausted of
formed elements and at times filled with eosinophilic debris.
Leydig cells were present and hyperplasia of interstitial cells
was seen, with massive infiltration of leukocytes. Blood tes-
tosterone levels were in the normal range and Leydig cells were
responsive to gonadotropins. Libido was intact. The method was
applicable to a variety of mammalian species. The implications
of the results are discussed.
Numerous attempts are being made to develop new methods
for control of male fertility. Progestogens have been used to
suppress the production and, possibly, the maturation of sperm
cells (1-4). Dosages required to achieve azospermia, however,
appear to vary widely from individual to individual;
pregnancies have been recorded in couples in whom the male
partner was seemingly on high dose, which, however, produced
in him only oligospermia and not azospermia (4). Intake of these
steroids is accompanied by undesirable side effects, such as loss
of libido (4, 5), presumably by virtue of their antiandrogenic
action (6), thus demanding the supplementation of the regime
with androgens (7).
As an alternative to steroidal contraception, the feasibility
of immunization against a number of sperm antigens is being
explored. The most promising of the sperm-specific antigens
are LDH-x (8) and acrosin (9). A major limitation in their
practical use is the difficulty in producing potent immune re-
sponse in iso- or heterospecies; in spite of recourse to strong
adjuvants such as Freund's complete adjuvant, a reduction, but
not complete block, of fertility is obtained in test animals
(10).
This communication describes a simple and effective pro-
cedure for achieving aspermatogenesis in mammals. The
method is based on the rationale that the body's immune system
is tolerant to only those testicular constituents that are made and
functional during fetal life. New proteins emerging with the
onset of spermatogenesis in postnatal years are "foreign" to the
immune system and intrinsically elicit immune response if the
opportunity is given to do so. The validity of this hypothesis is
supported by the frequent formation of antisperm antibodies
in subjects undergoing vasectomy operations (11), a situation
in which sperm cells escape the testicular barrier and are within
reach of the immunocompetent cells. Indeed, autoallergic or-
chitis has been produced in the past (12-16) by injection of
testicular extracts and Freund's complete adjuvant. This ad-
juvant, however, is not a permissible one for eventual male use.
We propose the use of a possibly acceptable agent that gives the
immunocompetent cells access to tubules and renders the tu-
bules largely free of spermatozoa. In arriving at this agent,
several other considerations were kept in mind. (i) It should be
effective in most, if not all, of the recipients; (ii) It should be an
agent that has been approved for human use and about which
clinical experience over several decades is available. This will
shorten the estimated 10-15 years considered necessary by
experts for safety studies on a new contraceptive. (iii) The same
agent should be effective not only in primates, but also in
common laboratory animals so as to make possible large-scale
safety studies at minimal cost. The requirements for baboons,
apes, and homologous 3 subunit of choriogonadotropin have
been a serious limitation to the speedy development of vaccines
against human choriogonadotropin (17, 18) and have added
enormously to the cost. (iv) Last, but not the least important,
would be the desirability of imparting additional immuno-
prophylactic benefits of therapy to the recipient besides the
control of fertility.
MATERIALS AND METHODS
Reagents. Bacillus Calmette-Guerin (BCG) was either from
BCG Vaccine Laboratories (Madras, India) or a product of the
Connaught Laboratories (Toronto, Ontario). The lyophilized
material was reconstituted in sterile, pyrogen-free isotonic saline
(0.9% NaCl, wt/vol). A unit of BCG contained 108 bacilli (from
Madras) or consisted of 0.1 mg of lyophilized material (from
Connaught Laboratories).
Immunization. Rats were given a single injection of 7.5 units
of BCG in 0.2 ml of saline in each testis with a 25-gauge needle.
In dogs, 110 units of BCG suspended in 1.5 ml of saline was
given in a single injection into each testis. In rhesus monkeys,
100 units in 1.5 ml was given bilaterally. The needle was in-
serted from one pole of the testis and pushed gently to the other,
with the material deposited at various points. The controls were
injected with an equal volume of isotonic saline.
Semen Analysis. Semen was obtained from dogs by mas-
turbation. The semen from rhesus monkeys was collected by
the electroejaculation technique of Mastroianni and Manson
(19) by use of two penile electrodes. The semen was incubated
at 37°C for 30 min for liquefaction.
Sperm Counts. A Neubauer counting chamber was used for
counting sperm at various dilutions of the semen (1:2, 1:10, 1:50,
or 1:100).
Abbreviation: BCG, bacillus Calmette-Gu6rin.
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Spermatozoan Motility. A drop of fresh or liquefied semen
was taken on a slide and covered with a cover slip; five fields
were counted under high power. The motility was expressed
on a 0-5 scale, where 0 indicated no motile sperm, 1 indicated
20% of sperm motile, 2 indicated 40% of sperm motile, and so
on.
Spermatozoan Viability. One drop of the semen after liq-
uefaction was incubated at 370C with a drop of eosin/nigrosin
stain. A thin smear was prepared on a clear slide, air dried, and
mounted in DPX mountant (BDH chemical). One hundred cells
were counted under oil immersion. The dead sperm cells
stained with eosin; living cells did not take the dye.
Histology. The testes, after dissection, were fixed in Bouin's
solution. The tissues were transferred to a supersaturated so-
lution of lithium carbonate in 70% alcohol for 24 hr, followed
by passage through graded dilutions of alcohol. Paraffin blocks
were made, and 5- to 6-Mm-thick deparaffinized sections were
stained with either hematoxylin/eosin or periodic acid Schiffs
stain/hematoxylin.
Testosterone Estimation. Rats were bled by retro-orbital
puncture with glass capillaries. Blood was drawn in heparinized
syringes from veins of fore or hind limbs in dogs and monkeys.
Plasma testosterone was estimated by radioimmunoassay.
RESULTS
The method was found to be applicable to a variety of mam-
malian species. It has been tested successfully in 98 rats, 24
guinea pigs, 13 rabbits, 18 dogs, 3 rams, and 3 rhesus monkeys.
Typically, a single injection of BCG, in adequate doses, caused
the tubules to be largely free of sperm cells. An equal volume
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FIc(. 1. Photomicrographs of rat testes immunized with 7.5 units ofBCG on day 76 (d-f) and day 28 (g and i) after immunization. Sections
of testes from normal rats injected with saline only and processed under identical conditions are included for comparison (a-c and h). a-f and
h are stained with hematoxylin/eosin; g and i with periodic acid/Schiff stain/hematoxylin. (a and d, X100; b and e, X250; c, f, and h, X1000;
g, X500; and i, X1250.)
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FIG. 2. Plasma testosterone values in control (A) and immunized
(B) rats before and 6 hr after intramuscular injection of 7.5 ,gg of
human gonadotropin (hCG).
of saline injected in the same way had no effect. The block to
sperm formation was complete in approximately 98% of tubules
examined in serial paraffin sections in rats; about 2% of the
tubules had apparently normal appearance. Whether these
were producing sperm in significant number is difficult to
discern from histological sections. The few sperm that were
found in the semen of immunized dogs, rams, and monkeys
were invariably immotile. The basement membrane was intact
in all tubules and the peritubular cell layer was normal. Tubules
were partially or fully atrophied in almost equal proportion.
In the partially atrophied tubules, different types of germinal
cells up to, at most, the spermatid stage could be seen. The
Sertoli cells had normal nuclei, but the cytoplasm was vacuo-
lated and, in most cells, partially disintegrated. The lumen at
times contained eosinophilic debris. In a few tubules, multi-
nucleated giant cells were seen occasionally. Fig. 1 shows the
typical histological features of testes in control and experimental
rats. In the interstitial spaces, leukocyte infiltration was evident.
82i
E 62-
O 42-
X 22-
E 2.0
a 0.6-
0.4-
0.2-
-z
5-4
04-
3-
2-
1
t
The Leydig cells with normal cytoarchitecture were discernible
(Fig. ii). Whether their number was increased is difficult to
ascertain with certainty. In most cases, hyperplasia of interstitial
cells was seen.
Leydig cell function was not impaired, as gauged by random
plasma testosterone levels, which were in the same range as in
control animals (Fig. 2). To exclude the possible contribution
to blood of androgens from the adrenal cortex (instead of from
the testes), we determined blood testosterone in immunized rats
after injection of a load dose of gonadotropin. This hormone
selectively stimulates steroidogenesis in the Leydig cells but does
not stimulate steroidogenesis in the adrenal cortex. A rise in
blood androgen level was seen in all immunized animals (Fig.
2). Similar results were obtained in several other species of
animals, complete data on which will be described else-
where.
Sperm Count and Motility. The sperm count in semen de-
clined rapidly after immunization. In general, very low sperm
counts were obtained in semen samples after 4-6 weeks of
immunization. Figs. 3 and 4 are representative examples in a
dog and a rhesus monkey. The few sperm, when present, were
mostly immotile. Semen remained free of sperm in these ani-
mals for almost 6-8 months. Long-term suppression of sper-
matogenesis was thus obtained in these species. It is difficult to
state at this stage whether the block of spermatogenesis is re-
versible or permanent. Perhaps it could be made reversible
either by intrinsic spontaneous regeneration and repair or by
chemotherapy with antimycobacterial drugs.
Libido. Dogs, rams, and monkeys immunized intratesticu-
larly with BCG and whose semen lacked or-contained a very
low number of immotile sperm cells did not demonstrate lack
of libido. Rams mounted on ewes and donated semen which
was, however, free of sperm cells. Dogs retained attraction for
a bitch in heat and engaged in copulation. Rhesus monkeys
mated with a female in the estrus phase of the cycle.
Side Effects. A side effect of the procedure was scrotal
swelling and pain, especially in animals given high doses of
BCG in large volumes of saline. These effects were minimized
with diminution of the injected dose. Local effects usually
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FIG. 3. Analysis of semen of a dog on different days after immunization with 110 units of BCG. The dog mounted and copulated normally
with a bitch in heat on the 34th day after immunization. The copulation was, however, infertile. Arrows, day of injection of BCG.
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FIG. 4. Effect of intratesticular immunization with 100 units of
BCG on sperm count, motility, viability, and weight of the semen from
a rhesus monkey. Arrows, day of injection.
subsided within 2 weeks in dogs. The local swelling and pain
as a result of immunization were not noted in the three rhesus
monkeys investigated, who were given 50, 100, and 160 units
per testis in 1.5 ml of saline.
The present mode of immunization is otherwise largely free
of systemic effects. A transient pyrexia was observed in rams
at very high dose, but was not noted in dogs and other animals
on low and moderate doses. The weight record of the immu-
nized animals was indicative of lack of morbidity. Assays of
blood did not reveal significant alterations in serum proteins,
glucose, cholesterol, urea, creatinins, and bilirubin. Hemato-
logical values like hemoglobin and total and differential leu-
kocyte counts remained in the normal range. Detailed data on
various species of animals will be reported elsewhere.
DISCUSSION
Satisfactory control of male fertility is considered to be achieved
only in situations in which viable motile sperm are fully pre-
vented from insemination in the female genital tract. A method
that produces only partial decrease in production (oligospermia)
or partial killing, as is the case with many spermicidal prepa-
rations, fails to impart fool-proof protection. One of the merits
of the method proposed in this communication is its ability to
produce nearly complete azospermia. The few sperm cells
present in the ejaculate were immotile.
Intervention at the site of production, as achieved in this
method, may be more reliable than immunological interception
through antibodies or sensitized cells in the female genital tract.
Leaving aside the difficulty in producing high enough immune
response in the female animal against sperm antigens without
recourse to strong and impermissible adjuvants, there will be
the uncertainty of inactivation of 100% of the spermatozoa by
the antibodies during the transit of the spermatozoa in the
genital tract. A single ejaculate may contain 30 million to 300
million sperm, and just a single sperm, reaching the vicinity of
the ovum in good state, can potentially cause fertilization.
Iso-immunization against sperm antigens is thus likely to have
practical difficulties of logistics in spite of laudable merits. This
is avoided in the present approach of eliciting an autoimmune
reaction against proteins developing with spermatozoa.
The dosages of BCG required for inducing damage confined
to germinal cell development should be worked out for each
species. Massive doses can bring about nonspecific tissue
damage, obliterating the basic structure. Previous sensitization
to BCG may reduce the dose requirement. The response, when
regulated properly with appropriate dose of the material, is
exercised selectively against only those constituents to which
the. immune system is not tolerant and which are not present
(or operative) during the fetal life. Thus, the basement mem-
brane, Leydig cells, and other structures made in embryonic
life are spared. By the same logic, it is expected that the immune
response generated will be discriminatory and will not operate
against other tissues considered as "self" components.
The choice of BCG for provoking autoimmune aspermato-
genesis was arrived at after experimenting on almost a dozen
other agents. The bacilli were effective in the killed state, but
the dose requirement was much higher and the action was lo-
calized around the point of deposition.
There may be additional benefits of using BCG. Guinea pigs
rendered aspermatic by intratesticular BCG developed delayed
hypersensitivity to tuberculin. Besides protection against tu-
berculosis, BCG is an adjuvant and has the property of stimu-
lating, in a general manner, the reticuloendothelial system, with
resultant improvement of immunological capacities against
infections. BCG therapy has also been reported to be beneficial
in cancers (20).
The present method spares surgery. Its side effects, if any,
need to be carefully studied in model experimental animals.
An advantage is the lack of fall in blood testosterone levels and
retention of libido in a situation where spermatogenesis is nearly
completely arrested.
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